Gardnerella Species and their Association with Bacterial Vaginosis.

Gardnerella bacterial vaginosis cpn60

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
24 Jan 2024
Historique:
received: 22 09 2023
revised: 10 01 2024
accepted: 19 01 2024
medline: 25 1 2024
pubmed: 25 1 2024
entrez: 25 1 2024
Statut: aheadofprint

Résumé

Bacterial vaginosis (BV) is a condition marked by high vaginal bacterial diversity. Gardnerella vaginalis has been implicated in BV but is also detected in healthy women. The Gardnerella genus has been expanded to encompass six validly named species and several genomospecies. We hypothesized that particular Gardnerella species may be more associated with BV. Quantitative PCR assays were developed targeting the cpn60 gene of species groups including G. vaginalis, G. piotii/pickettii, G. swidsinskii/greenwoodii and G. leopoldii. These assays were applied to vaginal swabs from individuals with (n=101) and without BV (n=150) attending a sexual health clinic in Seattle, Washington. Weekly swabs were collected from 42 participants for up to 12 weeks. Concentrations and prevalence of each Gardnerella species group were significantly higher in participants with BV. 91.1% of BV positive participants had three or more Gardnerella species groups detected compared to 32.0% of BV negative participants (p<0.0001). BV negative participants with three or more species groups detected were more likely to develop BV within 100 days versus those with fewer (60.5% vs 3.7%, p<0.0001). These results suggest that BV reflects a state of high Gardnerella species diversity. No Gardnerella species group was a specific marker for BV.

Sections du résumé

BACKGROUND BACKGROUND
Bacterial vaginosis (BV) is a condition marked by high vaginal bacterial diversity. Gardnerella vaginalis has been implicated in BV but is also detected in healthy women. The Gardnerella genus has been expanded to encompass six validly named species and several genomospecies. We hypothesized that particular Gardnerella species may be more associated with BV.
METHODS METHODS
Quantitative PCR assays were developed targeting the cpn60 gene of species groups including G. vaginalis, G. piotii/pickettii, G. swidsinskii/greenwoodii and G. leopoldii. These assays were applied to vaginal swabs from individuals with (n=101) and without BV (n=150) attending a sexual health clinic in Seattle, Washington. Weekly swabs were collected from 42 participants for up to 12 weeks.
RESULTS RESULTS
Concentrations and prevalence of each Gardnerella species group were significantly higher in participants with BV. 91.1% of BV positive participants had three or more Gardnerella species groups detected compared to 32.0% of BV negative participants (p<0.0001). BV negative participants with three or more species groups detected were more likely to develop BV within 100 days versus those with fewer (60.5% vs 3.7%, p<0.0001).
CONCLUSIONS CONCLUSIONS
These results suggest that BV reflects a state of high Gardnerella species diversity. No Gardnerella species group was a specific marker for BV.

Identifiants

pubmed: 38268121
pii: 7588781
doi: 10.1093/infdis/jiae026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

Matthew M Munch (MM)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Susan M Strenk (SM)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Sujatha Srinivasan (S)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Tina L Fiedler (TL)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Sean Proll (S)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

David N Fredricks (DN)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Department of Medicine, University of Washington, Seattle, WA, United States.

Classifications MeSH